journal article·2022-01Open access

Protein-corona formation on aluminum doped zinc oxide and gallium nitride nanoparticles

Vladimir Ciobanu, Francesco Roncari, Giacomo Ceccone, Tudor Braniste, Jessica Ponti, Alessia Bogni, Giuditta Guerrini, Domenico Cassano, Pascal Colpo, Ion Tiginyanu

Abstract

The interaction of semiconductor nanoparticles with bio-molecules attracts increasing interest of researchers, considering the reactivity of nanoparticles and the possibility to control their properties remotely giving mechanical, thermal, or electrical stimulus to the surrounding bio-environment. This work reports on a systematic comparative study of the protein-corona formation on aluminum doped zinc oxide and gallium nitride nanoparticles. Bovine serum albumin was chosen as a protein model. Dynamic light scattering, transmission electron microscopy and X-ray photoelectron spectroscopy techniques have been used to demonstrate the formation of protein-corona as well as the stability of the colloidal suspension given by BSA, which also works as a surfactant. The protein adsorption on the NPs surface studied by Bradford Assay showed the dependence on the quantity of proteins adsorbed to the available sites on the NPs surface, thus the saturation was observed at ratio higher than 5:1 (NPs:Proteins) in case of ZnO, these correlating with DLS results. Moreover, the kinetics of the proteins showed a relatively fast adsorption on the NPs surface with a saturation curve after about 25 min. GaN NPs, however, showed a very small amount of proteins adsorbed on the surface, a change in the hydrodynamic size being not observable with DLS technique or differential centrifugal sedimentation. The Circular Dichroism analysis suggests a drastic structural change in the secondary structure of the BSA after attaching on the NPs surface. The ZnO nanoparticles adsorb a protein-corona, which does not protect them against dissolution, and in consequence, the material proved to be highly toxic for Human keratinocyte cell line (HaCaT) at concentration above 25 µg/mL. In contrast, the GaN nanoparticles which do not adsorb a protein-corona, show no toxicity signs for HaCaT cells at concentration as high as 50 µg/mL, exhibiting much lower concentration of ions leakage in the culture medium as compared to ZnO nanoparticles.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National Center for Materials Study and Testing, Technical University of Moldova, Chisinau, Moldova

European Commission, Joint Research Center (JRC), Ispra, Italy

Academy of Sciences of Moldova, Chisinau, Moldova

Funding

Ministry of Education and Research of the Republic of Moldova · H2020 Spreading Excellence and Widening Participation

References (73)

Show source-provided references
1. 10.1039/C3MH00106G10.1039/C3MH00106G ↗
2. 10.1038/nnano.2011.5810.1038/nnano.2011.58 ↗
3. 10.3109/1743539090327694110.3109/17435390903276941 ↗
4. 10.1016/j.ijbiomac.2020.12.10810.1016/j.ijbiomac.2020.12.108 ↗
5. 10.1166/jnn.2016.1136110.1166/jnn.2016.11361 ↗
6. 10.1038/nnano.2012.23710.1038/nnano.2012.237 ↗
7. 10.1086/68959010.1086/689590 ↗
8. 10.1038/nnano.2013.18110.1038/nnano.2013.181 ↗
9. 10.1080/00986445.2016.116022510.1080/00986445.2016.1160225 ↗
10. Bozgeyik K · Int J Chem Reactor Eng · 2010 · 810.2202/1542-6580.2336 ↗
11. 10.1073/pnas.060858210410.1073/pnas.0608582104 ↗
12. 10.1016/S0939-6411(02)00089-910.1016/S0939-6411(02)00089-9 ↗
13. 10.3390/nano711037710.3390/nano7110377 ↗
14. 10.1016/j.colsurfa.2022.12966610.1016/j.colsurfa.2022.129666 ↗
15. 10.1007/s11705-018-1766-z10.1007/s11705-018-1766-z ↗
16. 10.1016/j.nanoen.2018.11.06110.1016/j.nanoen.2018.11.061 ↗
17. 10.1126/sciadv.170001510.1126/sciadv.1700015 ↗
18. 10.1126/sciadv.aba962410.1126/sciadv.aba9624 ↗
19. 10.1007/s13346-017-0448-610.1007/s13346-017-0448-6 ↗
20. 10.1021/mp100253e10.1021/mp100253e ↗
21. 10.4015/S101623720800065910.4015/S1016237208000659 ↗
22. 10.1021/la800716r10.1021/la800716r ↗
23. 10.1021/acsami.7b1564910.1021/acsami.7b15649 ↗
24. 10.1088/1361-6641/abe83e10.1088/1361-6641/abe83e ↗
25. 10.1016/j.spmi.2021.10696810.1016/j.spmi.2021.106968 ↗
26. 10.1109/JSEN.2022.315002710.1109/JSEN.2022.3150027 ↗
27. 10.1186/s11671-017-2262-y10.1186/s11671-017-2262-y ↗
28. 10.3762/bjnano.7.12410.3762/bjnano.7.124 ↗
29. 10.1166/jnn.2005.18210.1166/jnn.2005.182 ↗
30. 10.1371/journal.pone.005040510.1371/journal.pone.0050405 ↗
31. 10.1126/science.111649510.1126/science.1116495 ↗
32. 10.1126/science.109235610.1126/science.1092356 ↗
33. 10.1007/s13204-012-0174-910.1007/s13204-012-0174-9 ↗
34. 10.1021/jp104706q10.1021/jp104706q ↗
35. 10.1016/j.rinp.2017.04.01810.1016/j.rinp.2017.04.018 ↗
36. 10.1038/s41378-019-0102-110.1038/s41378-019-0102-1 ↗
37. 10.1016/j.matpr.2017.06.10810.1016/j.matpr.2017.06.108 ↗
38. 10.1016/j.mattod.2017.11.00310.1016/j.mattod.2017.11.003 ↗
39. 10.1007/s40820-015-0040-x10.1007/s40820-015-0040-x ↗
40. 10.1002/jbm.a.3078910.1002/jbm.a.30789 ↗
41. 10.1039/C4TB01661K10.1039/C4TB01661K ↗
42. 10.3390/nano804026810.3390/nano8040268 ↗
43. 10.1016/j.bbabio.2007.06.00410.1016/j.bbabio.2007.06.004 ↗
44. 10.1016/j.toxlet.2011.08.02610.1016/j.toxlet.2011.08.026 ↗
45. 10.1038/srep1387610.1038/srep13876 ↗
46. 10.1038/s42004-018-0054-710.1038/s42004-018-0054-7 ↗
47. 10.1016/j.cis.2006.05.00110.1016/j.cis.2006.05.001 ↗
48. 10.1016/j.jcis.2021.08.01310.1016/j.jcis.2021.08.013 ↗
49. 10.1006/abio.2000.488010.1006/abio.2000.4880 ↗
50. 10.1002/bip.2085310.1002/bip.20853 ↗
51. 10.1515/bnm-2013-000610.1515/bnm-2013-0006 ↗
52. 10.1021/la901453a10.1021/la901453a ↗
53. 10.3389/fbioe.2020.0021010.3389/fbioe.2020.00210 ↗
54. 10.1021/nn302995310.1021/nn3029953 ↗
55. 10.3109/17435390.2010.48972410.3109/17435390.2010.489724 ↗
56. 10.1116/6.000066110.1116/6.0000661 ↗
57. 10.1021/jp305267d10.1021/jp305267d ↗
58. 10.1021/acsaelm.0c0102310.1021/acsaelm.0c01023 ↗
59. 10.1016/j.apsusc.2014.11.08210.1016/j.apsusc.2014.11.082 ↗
60. 10.1016/S0167-577X(02)00713-910.1016/S0167-577X(02)00713-9 ↗
61. 10.1111/j.1151-2916.1996.tb08977.x10.1111/j.1151-2916.1996.tb08977.x ↗
62. 10.1016/S1748-0132(08)70014-810.1016/S1748-0132(08)70014-8 ↗
63. 10.1021/cr100440g10.1021/cr100440g ↗
64. 10.1002/etc.70810.1002/etc.708 ↗
65. 10.1007/s11051-020-04949-w10.1007/s11051-020-04949-w ↗
66. 10.1186/s12989-020-00379-710.1186/s12989-020-00379-7 ↗
67. 10.1021/la101033n10.1021/la101033n ↗
68. 10.1016/j.colsurfb.2009.08.04910.1016/j.colsurfb.2009.08.049 ↗
69. 10.1039/C6NR05306H10.1039/C6NR05306H ↗
70. 10.1007/s11051-009-9711-110.1007/s11051-009-9711-1 ↗
71. 10.1016/j.actbio.2011.09.03810.1016/j.actbio.2011.09.038 ↗
72. 10.1557/S109257830000011910.1557/S1092578300000119 ↗
73. 10.1016/j.bcab.2021.10211710.1016/j.bcab.2021.102117 ↗